Navigation Links
Boehringer Ingelheim Presents Progression-Free Survival Data for Investigational Afatinib and Nintedanib in Advanced NSCLC
Date:5/15/2013

which are types of enzymes measured to determine liver health[7] – as well as diarrhea (3% versus 1%) were observed in patients treated with nintedanib plus pemetrexed.2 Hypertension, bleeding, thrombosis, mucositis and neuropathy (greater than or equal to grade 3) were comparable between the two treatment arms.2 No increase in serious adverse events or grade five adverse events was observed in patients who received the combination of nintedanib plus pemetrexed.2

This study is part of the comprehensive LUME-Lung clinical trial program that is investigating nintedanib in different lung cancer treatment settings. Results from a second trial in the nintedanib LUME-Lung program will be presented on June 3 at ASCO.

About NSCLC and EGFR Mutations

NSCLC is the most common form of lung cancer, accounting for about 85 percent of all diagnoses.8 Between 10 and 15 percent of Caucasians and approximately 40 percent of Asians with NSCLC have EGFR mutations9 – 90 percent of which are the result of two mutations (Del19 or L858R).10

About Afatinib

Afatinib is an investigational, oral, once-daily irreversible ErbB Family Blocker that specifically inhibits epidermal growth factor receptor (EGFR or ErbB1), human epidermal receptor 2 (HER2 or ErbB2) and ErbB4. It is currently in Phase III clinical development in advanced NSCLC and head and neck cancer. The company has submitted applications requesting the review of afatinib for patients with EGFR mutation-positive advanced NSCLC to regulatory authorities in a number of countries and regions worldwide, including the U.S., E.U. and Asia.

Afatinib is not approved by the FDA; its safety and efficacy have not been established. 

About Nintedanib

Nintedanib (BIBF 1120) is an investigational orally-administered triple angiokinase inhibitor that targets three of the receptor
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Boehringer Ingelheim Announces Launch of GLORIA™-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation
2. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
3. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
4. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
5. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
6. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
7. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
8. Boehringer Ingelheim announces afatinib expanded access program (EAP) for patients with EGFR mutation-positive advanced NSCLC
9. Whistleblowers extraordinary efforts helped win $95 million settlement with Boehringer Ingelheim
10. Phase 2b Data of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% of Treatment-Naive Patients
11. Boehringer Ingelheim Announces Equine Research Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Sept. 23, 2014   MedNet Solutions , a global ... is pleased to announce that it will once again be ... (SCDM) Annual Conference, to be held this year from September ... , Nevada. MedNet team members, in conjunction with representatives from many ... will also be in attendance, will be providing demonstrations of ...
(Date:9/23/2014)... ORLANDO, Fla. and DUBLIN ... Inc. (OTC-BB: TNIB) ("we" or the "Company"), a ... innovative therapies for autoimmune diseases in emerging nations, ... has approved our common stock for DTC,s Deposit ... Fast Automated Securities Transfer Service ("FAST") transfer agent ...
(Date:9/23/2014)... Sept. 23, 2014  Hill-Rom (NYSE: HRC ... Health ( Renton, WA ), the nation,s ... the companies, existing relationship as Hill-Rom now becomes Providence ... capital bed frame and surface products. ... in the U.S.  It operates 34 hospitals, 475 physician ...
Breaking Medicine Technology:MedNet Solutions - Proud To Sponsor The SCDM 2014 Annual Conference 2TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 2TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 3TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 4Hill-Rom Announces Seven-Year, Sole-Source Contract with Providence Health 2
... SILVER SPRING, Md., May 2, 2011 The U.S. ... used with diet and exercise, to improve blood glucose ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) People with Type ... insulin, a hormone that regulates the amount of glucose ...
... and SEATTLE, May 2, 2011 CMC Biologics, ... in Copenhagen, Denmark and Seattle, Washington USA, announced ... serve at its Chief Executive Officer. CMC Biologics, ... delivering  world class, fully integrated, biopharmaceutical process development ...
Cached Medicine Technology:FDA Approves New Treatment for Type 2 Diabetes 2CMC Biologics Announces Appointment of New CEO 2
(Date:9/23/2014)... By Kathleen Doheny ... -- For babies born at very low birth weights, breast ... to a potentially dangerous infection known as cytomegalovirus (CMV), a ... very low birth weight infants -- all of whom weighed ... mothers with a history of CMV infection, to see whether ...
(Date:9/23/2014)... medicine is rapidly developing, bringing with its advances ... optimize prevention and treatment interventions. Genetic tests ... virus (HIV) and hepatitis c virus (HPC), and ... used to screen for an individual,s susceptibility to ... for addiction. , While there appear to be ...
(Date:9/23/2014)... (PRWEB) September 23, 2014 What: ... Manhattan’s Upper West Side that embodies the inclusion ... Eden: Christians, Scripture and the Ecological Crisis, a ... B. Rhodes Professor Emerita of Old Testament at ... for ancient wisdom that lends insight into current ...
(Date:9/23/2014)... Men who are already obese as teenagers could grow ... their peers of normal weight. So says Petter Lundborg ... Dan-olof Rooth of Linneas University and Lund University, all ... the United Kingdom and the United States, and the ... , The researchers analyzed large-scale data of 145,193 ...
(Date:9/23/2014)... Mission Viejo, California (PRWEB) September 23, 2014 ... in the Oracle services market. Included are ... Oracle Resource Augmentation. Trevera supports all versions of ... and associated point releases. , Trevera has ... specifically for organizations that need help with their ...
Breaking Medicine News(10 mins):Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 2Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 3Health News:NYU-Mount Sinai Beth Israel study explores drug users' opinions on genetic testing 2Health News:Inhabiting Eden: Christians, Scripture, and the Ecological Crisis – Public Lecture to Discuss Faith-Based Environmentalism 2Health News:Note to young men: Fat doesn't pay 2Health News:Trevera, Inc adds Management Support to Services 2Health News:Trevera, Inc adds Management Support to Services 3
... the latest salvo in the pay-for-performance medicine, one of the ... plan to rate physicians on its network based on the ... means that patients will be allowed to choose the doctor ... patients. Naturally, doctors are not amused by this idea. United ...
... New Zealand President Murray Dear is not happy with the ... The statistics show that only 60% of diabetic patients // ... diabetics, which is a state, funded program. , ,The ... to the people that diabetics is not properly monitored it ...
... mats spread across the walls of a patient's room ... skin diseases, hypertension and rheumatic complaints, a study says.//,A ... said patients kept in medicated rooms were cured in ... ,The study involved 36 patients, of whom 19 ...
... to chill Chilling can result in bring on common cold ... also approves ratifies the conventional wisdom of mothers about cold. ... without a hat or with wet hair. Since the early ... the online edition of ABC News. , ,Ron Eccles, ...
... overcome from the crisis if a possible epidemic strikes ... flu strikes Japan it could cause more than 64,000 ... have a cabinet meeting next week to discuss various ... cabinet ministers to prepare preventive measures and emergency measures ...
... has attacked the health profession for complacency in its preparations ... a “biological inevitability”. //, ,Last week Donaldson called together ... colleges, to emphasize that the disease could kill between 50,000 ... joke. , He is planning to issue a “protect ...
Cached Medicine News:Health News:Now medicated coir to cure ailments 2Health News:Doctors attacked for complacency against pandemic threat 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: